INCYTE revenue breakdown overview

INCYTE revenue for the last year amounted to 4.10 B EUR, the most of which — 4.12 B EUR — came from its highest performing source at the moment, Oncology and Dermatology Pharmaceutical Products, the year earlier bringing 3.33 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought INCYTE 3.86 B EUR, and the year before that — 3.17 B EUR.